Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Feb 15;13(2):175-182.
doi: 10.5664/jcsm.6440.

Ready-Made Versus Custom-Made Mandibular Repositioning Devices in Sleep Apnea: A Randomized Clinical Trial

Affiliations
Randomized Controlled Trial

Ready-Made Versus Custom-Made Mandibular Repositioning Devices in Sleep Apnea: A Randomized Clinical Trial

Ama Johal et al. J Clin Sleep Med. .

Abstract

Study objectives: To compare the effectiveness of a custom-made (MRDc) versus ready-made (MRDr) mandibular repositioning devices (MRD) in the management of obstructive sleep apnea (OSA).

Methods: A randomized crossover trial design was adopted in which patients with a confirmed diagnosis of OSA were randomly allocated to receive either a 3-month period of ready-made or custom-made MRD, with an intervening washout period of 2 weeks, prior to crossover. Treatment outcomes included both objective sleep monitoring and patient-centered measures (daytime sleepiness, partner snoring and quality of life).

Results: Twenty-five patients, with a mild degree of OSA (apnea-hypopnea index of 13.3 [10.9-25] events/h) and daytime sleepiness (Epworth Sleepiness Scale of 11 [6-16]), completed both arms of the trial. The MRDc achieved a complete treatment response in 64% of participants, compared with 24% with the MRDr (p < 0.001). A significant difference was observed in treatment failures, when comparing the MRDr (36%) with the MRDc (4%). Excessive daytime sleepiness (Epworth Sleepiness Scale ≥ 10) persisted in 33% (MRDc) and 66% (MRDr) of OSA subjects, following treatment. A statistically significant improvement was observed in quality of life scales following MRDc therapy only. Significant differences were observed in relation to both the number of nights per week (p = 0.004) and hours per night (p = 0.006) between the two different designs of device.

Conclusions: The study demonstrates the significant clinical effectiveness of a custom-made mandibular repositioning device, particularly in terms of patient compliance and tolerance, in the treatment of OSA.

Keywords: appliance; clinical studies; clinical trial; sleep disorders; therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1. The custom-made mandibular repositioning device (MRDc), that permitted incremental mandibular advancement to be achieved.
Figure 2
Figure 2. The ready-made mandibular repositioning device (MRDr).
Figure 3
Figure 3. Consort flow diagram.

Similar articles

Cited by

References

    1. Horne J, Reyner L. Sleep related vehicle accidents. BMJ. 1995;310(6979):565–567. - PMC - PubMed
    1. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: a population study. BMJ. 2008;320(7233):479–482. - PMC - PubMed
    1. Pataka A, Riha RL. Continuous positive airway pressure and cardiovascular events in patients with obstructive sleep apnea. Curr Cardiol Rep. 2013;15(8):385. - PubMed
    1. Continuous positive airway pressure for the treatment of obstructive sleep apnoea/hypopnoea syndrome. National Institute for Health and Care Excellence Web site. [Accessed January 5, 2017]. https://www.nice.org.uk/guidance/ta139. Published March 26, 2008.
    1. Ramar K, Dort LC, Katz SG, et al. Clinical practice guidelines for the treatment of obstructive sleep apnea and snoring with oral appliance therapy: an update for 2015. J Clin Sleep Med. 2015;11(7):773–827. - PMC - PubMed

Publication types